Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09TYM
|
||||
Former ID |
DNC004402
|
||||
Drug Name |
LEUKOTRIENE_B4
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551272] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H32O4
|
||||
Canonical SMILES |
CCCCCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O
|
||||
InChI |
1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7+,9-6-,14-10+,15-11-/t18-,19-/m1/s1
|
||||
InChIKey |
VNYSSYRCGWBHLG-AMOLWHMGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 2 | Target Info | Inhibitor | [551245] | |
Leukotriene B4 receptor 1 | Target Info | Inhibitor | [551272] | ||
NetPath Pathway | IL4 Signaling Pathway | ||||
References | |||||
Ref 551245 | Diaryl ether/carboxylic acid derivatives of LY255283: Receptor antagonists of leukotriene B4, Bioorg. Med. Chem. Lett. 3(10):1985-1990 (1993). | ||||
Ref 551272 | Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity, Bioorg. Med. Chem. Lett. 4(6):811-816 (1994). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.